Product
HAIC+targeted therapy+PD-1 inhibitor
1 clinical trial
4 indications
Indication
Liver Metastasis Colon CancerIndication
ctDNA GenotypeIndication
MSSIndication
Failed From Standard TreatmentClinical trial
Targeted Treatment Based on ctDNA Genotyping Combined With Tislelizumab and HAIC as Salvage Treatment for Advanced Colorectal Cancer Liver Metastasis Failed From Standard Systemic Treatment (SALVLIV Trial)Status: Recruiting, Estimated PCD: 2026-01-23